Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Currently, Catherine M. Bonuccelli occupies the position of Chief Medical Officer of BELLUS Health, Inc. Dr. Bonuccelli is also on the board of Biotechnology Innovation Organization and Member-Managers Board at The Nemours Foundation.

She previously was VP-Global Medicines Clinical Inflammation at AstraZeneca Plc, Head-US Medical Affairs Respiratory at GlaxoSmithKline Plc, Assistant Director at Astra Zeneca Pharmaceuticals Philippines, Inc., Medical Director for Medical Research Group, Inc. and Assistant Professor at the University of Virginia.

She received an undergraduate degree from Georgetown University and a graduate degree from The Johns Hopkins University.

Current positions of Catherine M. Bonuccelli 
NameTitle Since
BELLUS Health Inc.
(Biotechnology & Medical Research)
Chief Medical Officer 2019
Biotechnology Innovation Organization Director -
The Nemours Foundation Member-Managers Board 2012

Holdings of Catherine M. Bonuccelli 
BELLUS Health Inc. (BLU)
(Biotechnology & Medical Research)
00.0000%0 USD

Catherine M. Bonuccelli: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
05/02ELON MUSK : Musk seeks to put in less money in new Twitter deal financing -sources
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
05/03Stocks rise, U.S. yields slip as markets await Fed rate hike
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
05/03ELON MUSK : Elon Musk plans to take Twitter public again later - WSJ
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
More news

© 2022 People and Ownership :   
Catherine M. Bonuccelli : Connections